Access Resources
5651 - 5700 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Domain-specific cognitive impairment in non-demented Parkinson's disease psychosisJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 33Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.4736Best OA location URL: https://europepmc.org/articles/pmc5698175?pdf=renderCitation Count: 9
-
RESTRICTEDTitle: Motor Complications of Dopaminergic Medications in Parkinson's DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 37Issue #: 02Start Page: 147End Page: 157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0037-1602423Best OA location URL: https://europepmc.org/articles/pmc5990008?pdf=renderCitation Count: 53
-
RESTRICTEDTitle: Neuropsychological Subgroups in Non-Demented Parkinson’s Disease: A Latent Class AnalysisJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 7Issue #: 2Start Page: 385End Page: 395Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-171081Best OA location URL: https://europepmc.org/articles/pmc5548408?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Recognizing Atypical Parkinsonisms: “Red Flags” and Therapeutic ApproachesJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 37Issue #: 02Start Page: 215End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0037-1602422Best OA location URL: https://europepmc.org/articles/pmc5961706?pdf=renderCitation Count: 26
-
RESTRICTEDTitle: The Phenomenology of Parkinson's DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 37Issue #: 02Start Page: 109End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0037-1601869Best OA location URL: https://europepmc.org/articles/pmc5961724?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: VPS35, the Retromer Complex and Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 7Issue #: 2Start Page: 219End Page: 233Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-161020Best OA location URL: https://europepmc.org/articles/pmc5438477?pdf=renderCitation Count: 124
- Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease2017RESTRICTEDTitle: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 43Issue #: 7Start Page: 604End Page: 620Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12402Best OA location URL: https://europepmc.org/articles/pmc5632188?pdf=renderCitation Count: 51
-
RESTRICTEDTitle: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 955End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27038Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27038Citation Count: 174
-
RESTRICTEDTitle: Which ante mortem clinical features predict progressive supranuclear palsy pathology?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 995End Page: 1005Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27034Best OA location URL: https://europepmc.org/articles/pmc5543934?pdf=renderCitation Count: 121
-
RESTRICTEDTitle: Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's DiseaseJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 6Start Page: 578End Page: 585Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205014666170203093219Best OA location URL: https://europepmc.org/articles/pmc6091859?pdf=renderCitation Count: 9
-
RESTRICTEDTitle: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an UpdateJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 5Start Page: 973End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440Citation Count: 34
- Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation2017RESTRICTEDTitle: Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-01587-6Best OA location URL: https://www.nature.com/articles/s41598-017-01587-6.pdfCitation Count: 33
-
RESTRICTEDTitle: Limbic grey matter changes in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 7Start Page: 3566End Page: 3578Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.23610Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23610Citation Count: 21
- Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease2017RESTRICTEDTitle: Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 38Issue #:Start Page: 31End Page: 34Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.008Best OA location URL: https://europepmc.org/articles/pmc5400012?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: Lewy Body DisordersJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 325End Page: 338Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2017.01.004Best OA location URL: https://europepmc.org/articles/pmc5912679?pdf=renderCitation Count: 50
-
RESTRICTEDTitle: RIC3 variants are not associated with Parkinson's disease in French-Canadians and FrenchJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 53Issue #:Start Page: 194.e9End Page: 194.e11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.01.005Best OA location URL: http://escholarship.mcgill.ca/downloads/47429g00rCitation Count: 5
- Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss2017RESTRICTEDTitle: Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron lossJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 60Issue #:Start Page: 99End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.03.008Best OA location URL: https://europepmc.org/articles/pmc5499677?pdf=renderCitation Count: 34
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease2017RESTRICTEDTitle: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 291Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012Citation Count: 16
-
RESTRICTEDTitle: GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 14Start Page: 2747End Page: 2767Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddx161Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/14/2747/24340312/ddx161.pdfCitation Count: 62
- The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK22017RESTRICTEDTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://europepmc.org/articles/pmc6178381?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activityJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0174-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0174-zCitation Count: 61
-
RESTRICTEDTitle: Endoplasmic reticulum proteostasis impairment in agingJournal Name: Aging CellPublisher: WileyVol: 16Issue #: 4Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.12599Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.12599Citation Count: 162
- Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway2017RESTRICTEDTitle: Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathwayJournal Name: HippocampusPublisher: WileyVol: 27Issue #: 7Start Page: 784End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hipo.22731Best OA location URL: https://europepmc.org/articles/pmc5501956?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Imaging genetics approach to Parkinson’s disease and its correlation with clinical scoreJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep46700Best OA location URL: https://doi.org/10.1038/srep46700Citation Count: 12
- Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress2017RESTRICTEDTitle: Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0862-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0862-1Citation Count: 24
- An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression2017RESTRICTEDTitle: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 11Issue #: 7-8Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.201700045Best OA location URL: https://europepmc.org/articles/pmc5540649?pdf=renderCitation Count: 9
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
-
-
RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies2017RESTRICTEDTitle: Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 11Start Page: 1237End Page: 1250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.03.001Best OA location URL: https://europepmc.org/articles/pmc5647200?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
-
RESTRICTEDTitle: Targeted deletion of GD3 synthase protects against MPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 17
-
RESTRICTEDTitle: Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's DiseaseJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 37Issue #: 18Start Page: 4830End Page: 4840Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.2208-16.2017Best OA location URL: https://www.jneurosci.org/content/jneuro/37/18/4830.full.pdfCitation Count: 177
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017RESTRICTEDTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 27
-
RESTRICTEDTitle: Ubiquitin and Parkinson's disease through the looking glass of geneticsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1439End Page: 1451Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160498Best OA location URL: https://portlandpress.com/biochemj/article-pdf/474/9/1439/689414/bcj-2016-0498c.pdfCitation Count: 52
-
RESTRICTEDTitle: Integrated molecular landscape of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0015-3Best OA location URL: https://www.nature.com/articles/s41531-017-0015-3.pdfCitation Count: 91
- Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.32017RESTRICTEDTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 54
-
RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 38
- The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial Bioenergetics2017RESTRICTEDTitle: The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial BioenergeticsJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2017.00055Best OA location URL: https://www.frontiersin.org/articles/10.3389/fonc.2017.00055/pdfCitation Count: 37
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned2017RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 31
-
RESTRICTEDTitle: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant PathwaysJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 16Issue #: 4Start Page: 581End Page: 593Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/mcp.m116.061440Best OA location URL: https://www.mcponline.org/content/mcprot/16/4/581.full.pdfCitation Count: 49
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 11
- Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes2017RESTRICTEDTitle: Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging PhenotypesJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 4Start Page: 404End Page: 415.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2017.02.009Best OA location URL: http://www.cell.com/article/S2405471217300534/pdfCitation Count: 93
- Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine2017RESTRICTEDTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3Citation Count: 0
-
RESTRICTEDTitle: Probabilistic conversion of neurosurgical DBS electrode coordinates into MNI spaceJournal Name: NeuroImagePublisher: Elsevier BVVol: 150Issue #:Start Page: 395End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.004Best OA location URL: https://europepmc.org/articles/pmc6050588?pdf=renderCitation Count: 115
- Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses2017RESTRICTEDTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://europepmc.org/articles/pmc5386784?pdf=renderCitation Count: 33
-
RESTRICTEDTitle: The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseJournal Name: Biomarkers in MedicinePublisher: Future Medicine LtdVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 47
- Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses2017RESTRICTEDTitle: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0012-6Best OA location URL: https://www.nature.com/articles/s41531-017-0012-6.pdfCitation Count: 28
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia2017RESTRICTEDTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 32
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 29